009300 Stock Chart & Stats
₩12490.00
-₩10.00(-0.08%)
―
--
Day’s Range― - ―
52-Week Range₩12,040.00 - ₩18,590.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)4.48K
Market Cap
₩76.29B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)8.6
Beta0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,370,000
10 Day Avg. Volume5,044
30 Day Avg. Volume4,483
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
009300 FAQ
What was Sam-A Pharm. Co., Ltd.’s price range in the past 12 months?
Sam-A Pharm. Co., Ltd. lowest stock price was ₩12040.00 and its highest was ₩18590.00 in the past 12 months.
What is Sam-A Pharm. Co., Ltd.’s market cap?
Sam-A Pharm. Co., Ltd.’s market cap is ₩76.29B.
When is Sam-A Pharm. Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sam-A Pharm. Co., Ltd.’s earnings last quarter?
Sam-A Pharm. Co., Ltd. released its earnings results on May 14, 2026. The company reported ₩365.324 earnings per share for the quarter, beating the consensus estimate of N/A by ₩365.324.
Is Sam-A Pharm. Co., Ltd. overvalued?
According to Wall Street analysts Sam-A Pharm. Co., Ltd.’s price is currently Undervalued.
Does Sam-A Pharm. Co., Ltd. pay dividends?
Sam-A Pharm. Co., Ltd. does not currently pay dividends.
What is Sam-A Pharm. Co., Ltd.’s EPS estimate?
Sam-A Pharm. Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sam-A Pharm. Co., Ltd. have?
Sam-A Pharm. Co., Ltd. has 6,370,000 shares outstanding.
What happened to Sam-A Pharm. Co., Ltd.’s price movement after its last earnings report?
Sam-A Pharm. Co., Ltd. reported an EPS of ₩365.324 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.873%.
Which hedge fund is a major shareholder of Sam-A Pharm. Co., Ltd.?
Currently, no hedge funds are holding shares in KR:009300
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
KOREA PHARMA Co., Ltd.
―
iNtRON Biotechnology, Inc.
―
Icure Pharmaceutical Incorporation
―
Enzychem Lifesciences Corp.
―
DongKook Life Science Co., Ltd.
―